<DOC>
	<DOCNO>NCT00388024</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure , PET scan CT scan , may help doctor predict patient 's response treatment plan best treatment . PURPOSE : This clinical trial study well PET scan CT scan show response treatment patient locally advanced head neck cancer undergo chemotherapy radiation therapy .</brief_summary>
	<brief_title>PET Scans CT Scans Patients With Locally Advanced Head Neck Cancer Undergoing Chemotherapy Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine feasibility perform positron emission tomography-computed tomography ( PET-CT ) image early discrimination treatment response post-therapy neck management patient locally advance cancer head neck treat definitive chemoradiotherapy . Secondary - Perform semiquantitative analysis tracer uptake patient use standard uptake value qualitative analysis tracer uptake use pure visual analysis . - Determine feasibility distinguish benign malignant process initial tumor stag patient whole-body PET-CT imaging . - Correlate stag whole-body PET-CT image stag standard CT/MRI , clinical exam , pathologic specimen . - Determine feasibility PET-CT imaging patient treatment position radiotherapy treatment planning , correlate result standard CT/MRI image , record difference . - Perform PET-CT image patient week 2 4 chemoradiotherapy evaluate predictive value response treatment time point . - Determine time interval treatment monitor 6 12 week post chemoradiotherapy important predictive value PET-CT imaging . - Evaluate patient clinical radiographic abnormality worrisome residual recurrent disease PET-CT image 6 12 week post chemoradiotherapy ass need additional therapy ( i.e. , neck dissection ) . OUTLINE : This pilot study . Patients receive fludeoxyglucose F 18 ( FDG ) IV 90 second prior initial scan . Patients undergo whole-body compute tomography ( CT ) image contrast follow positron emission tomography ( PET ) imaging ( approximately 1 hour FDG injection ) initial stag simulation radiotherapy treatment planning . After PET-CT evaluation , patient locoregional disease recommend standard-care chemoradiotherapy . Patients evidence M1 disease confirm CT/MRI and/or biopsy treat discretion attend clinician . During chemoradiotherapy , patient undergo PET-CT imaging , describe , begin week 2 week 4 treatment monitor early detection recurrent residual disease . Follow-up PET-CT scan perform , describe previously , 6 week 3 month completion chemoradiotherapy . After completion study procedure , patient follow periodically 5 year .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Unknown Primary</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm squamous cell carcinoma lymphoepithelioma head neck , include follow site : Oral cavity Oropharynx Hypopharynx Larynx Nasopharynx Unknown primary head neck region Stage III IV disease Definitive chemoradiotherapy curative intent must plan PATIENT CHARACTERISTICS : Able tolerate positron emission tomography ( PET ) image Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No poorly control diabetes mellitus ( e.g. , fast glucose &gt; 200 mg/dL ) despite medication PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior radiotherapy head neck</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma oropharynx</keyword>
	<keyword>squamous cell carcinoma unknown primary</keyword>
	<keyword>newly diagnose carcinoma unknown primary</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
</DOC>